CINECA IRIS Institutional Research Information System

BARRESI, ELISABETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.753
AS - Asia 4.760
EU - Europa 3.849
SA - Sud America 575
Continente sconosciuto - Info sul continente non disponibili 378
AF - Africa 256
OC - Oceania 33
Totale 17.604
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.423
IT - Italia 1.663
SG - Singapore 1.394
CN - Cina 1.103
VN - Vietnam 924
HK - Hong Kong 574
BR - Brasile 442
DE - Germania 407
SE - Svezia 400
CA - Canada 229
FR - Francia 221
AT - Austria 195
GB - Regno Unito 183
BG - Bulgaria 180
FI - Finlandia 168
JP - Giappone 165
IN - India 145
RU - Federazione Russa 132
KR - Corea 73
TR - Turchia 68
BD - Bangladesh 58
CI - Costa d'Avorio 54
NL - Olanda 52
MX - Messico 51
PL - Polonia 46
IQ - Iraq 43
NG - Nigeria 42
AR - Argentina 39
SN - Senegal 39
UA - Ucraina 39
PK - Pakistan 37
ZA - Sudafrica 34
ES - Italia 32
AU - Australia 31
BE - Belgio 31
UZ - Uzbekistan 26
EG - Egitto 23
SA - Arabia Saudita 23
CH - Svizzera 22
VE - Venezuela 20
ID - Indonesia 19
EC - Ecuador 18
KE - Kenya 18
CO - Colombia 17
CZ - Repubblica Ceca 15
MA - Marocco 15
JO - Giordania 13
LT - Lituania 11
PY - Paraguay 11
AZ - Azerbaigian 10
DZ - Algeria 10
JM - Giamaica 10
AE - Emirati Arabi Uniti 9
TT - Trinidad e Tobago 9
CL - Cile 8
HU - Ungheria 8
IE - Irlanda 8
KZ - Kazakistan 8
ET - Etiopia 7
MY - Malesia 7
OM - Oman 7
PH - Filippine 7
BO - Bolivia 6
CR - Costa Rica 6
PE - Perù 6
TW - Taiwan 6
GE - Georgia 5
IL - Israele 5
LB - Libano 5
RO - Romania 5
UY - Uruguay 5
AL - Albania 4
EE - Estonia 4
IR - Iran 4
PA - Panama 4
BH - Bahrain 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
GY - Guiana 3
NI - Nicaragua 3
PR - Porto Rico 3
PT - Portogallo 3
BB - Barbados 2
BZ - Belize 2
GR - Grecia 2
HR - Croazia 2
KG - Kirghizistan 2
KW - Kuwait 2
MK - Macedonia 2
NO - Norvegia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
RS - Serbia 2
SO - Somalia 2
TH - Thailandia 2
ZM - Zambia 2
AW - Aruba 1
BA - Bosnia-Erzegovina 1
Totale 17.197
Salva come PNG Salva come JPEG
Città #
Ashburn 841
Singapore 765
San Jose 579
Serra 561
Hong Kong 540
Dallas 481
Santa Clara 412
Woodbridge 394
Fairfield 363
Ann Arbor 343
Chandler 332
Houston 311
Ho Chi Minh City 273
Hanoi 233
Council Bluffs 230
Shanghai 222
Beijing 200
New York 195
Los Angeles 179
Sofia 179
Seattle 172
Vienna 167
Ottawa 150
Wilmington 132
Frankfurt am Main 126
Boardman 125
Pisa 111
Hefei 110
Princeton 109
Tokyo 108
Cambridge 106
Milan 105
Helsinki 85
Lauterbourg 84
Munich 81
Lawrence 78
Medford 73
Des Moines 72
Seoul 67
Florence 56
Abidjan 54
Da Nang 49
Redondo Beach 49
São Paulo 49
London 48
Dearborn 47
Turku 47
Rho 41
Bremen 40
Dakar 39
Lagos 39
Rome 38
Buffalo 37
Haiphong 36
Istanbul 36
Lucca 35
Warsaw 35
Nanjing 31
Brussels 30
Livorno 28
Orem 27
Atlanta 26
Baltimore 26
Columbus 26
Dong Ket 25
Tashkent 25
San Diego 22
Sydney 22
Toronto 22
Montreal 21
Boulder 20
Chicago 20
Pune 20
Jacksonville 19
Paris 19
Pessac 19
Denver 18
Ogden 18
Fort Wayne 17
Johannesburg 17
Manchester 17
Nuremberg 17
Amsterdam 16
Cascina 16
Changsha 15
Dhaka 15
Fuzhou 15
Guangzhou 15
Izmir 15
Mexico City 15
Pistoia 15
Stockholm 15
Düsseldorf 14
Phoenix 14
Amman 13
Aversa 13
Baghdad 13
Chennai 13
Mooresville 13
Quanzhou 13
Totale 11.279
Salva come PNG Salva come JPEG
Nome #
Metformin conjugates and therapeutic use thereof 390
TSPO ligand residence time influences human glioblastoma multiforme cell death/life balance 335
18 kDa TSPO targeting drives polarized human microglia towards a protective and restorative neurosteroidome profile 318
Iminothioethers as Hydrogen Sulfide Donors: From the Gasotransmitter Release to the Vascular Effects 299
Benzofuroxane Derivatives as Multi Effective Agents for the Treatment of Cardiovascular Diabetic Complications. Synthesis, Functional Evaluation, and Molecular Modeling Studies 279
Apoptosis Therapy in Cancer: The First Single-molecule Co-activating p53 and the Translocator Protein in Glioblastoma 277
TSPO PIGA ligands promote neurosteroidogenesis and human astrocyte well-being 272
Two mixed valence diruthenium(ii,iii) isomeric complexes show different anticancer properties 259
The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities 246
Translocator Protein 18-kDa: a promising target to treat neuroinflammation-related degenerative diseases 246
Deepening the Topology of the Translocator Protein Binding Site by Novel N,N-Dialkyl-2-arylindol-3-ylglyoxylamides 244
Allosteric modulators of human A2B adenosine receptor. 235
Sulfonamides incorporating heteropolycyclic scaffolds show potent inhibitory action against carbonic anhydrase isoforms I, II, IX and XII 234
TSPO ligand residence time: a new parameter to predict compound neurosteroidogenic efficacy 233
A complex bearing TSPO PIGA ligand coordinated to the [Au(PEt3)]+ pharmacophore is highly cytotoxic against ovarian cancer cells 225
A mixed-valence diruthenium(ii,iii) complex endowed with high stability: from experimental evidence to theoretical interpretation 221
TSPO Radioligands for Neuroinflammation: An Overview 218
Long lasting inhibition of Mdm2-p53 interaction potentiates mesenchymal stem cell differentiation into osteoblasts 214
An update into the medicinal chemistry of translocator protein (TSPO) ligands 214
A cyanine-based NIR fluorescent Vemurafenib analog to probe BRAFV600E in cancer cells 213
Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of non-camptothecin Topoisomerase I (Top1) inhibitors 210
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: A Novel Template for the Design of Highly Selective A(2B) Adenosine Receptor Antagonists. 207
Benzothiopyranoindole- and pyridothiopyranoindole-based antiproliferative agents targeting topoisomerases 207
Arylthioamides as H2S Donors:l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo 205
Discovery of Pyrido[3′,2′:5,6]thiopyrano[4,3- d]pyrimidine-Based Antiproliferative Multikinase Inhibitors 204
New insights in the structure-activity relationships of 2-phenylamino-substituted benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors 202
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: a novel template for the design of highly selective A(2B) adenosine receptor antagonists 199
Drug-target Residence Time: a key parameter in glial responses to TSPO ligands 199
Residence Time (RT), a new parameter to predict neurosteroidogenic efficacy of Translocator Protein (TSPO) ligands: N,N-dialkyl-2-arylindol-3-ylglyoxylamides, a case study 198
Novel fluorescent triazinobenzimidazole derivatives as probes for labelling human A1 and A2B adenosine receptor subtypes 196
Translocator protein (tspo) ligand residence time: a new parameter to predict neurosteroidogenic efficacy for n,n-dialkyl-2-arylindol-3-ylglyoxylamides (PIGAs) 195
Novel positive allosteric modulators of A2B adenosine receptor acting as bone mineralisation promoters 192
Targeting TSPO Reduces Inflammation and Apoptosis in an In Vitro Photoreceptor-Like Model of Retinal Degeneration 190
Inhibition studies on carbonic anhydrase isoforms I, II, IV and IX with N-arylsubstituted secondary sulfonamides featuring a bicyclic tetrahydroindazole scaffold 189
New antiproliferative agents derived from tricyclic 3,4-dihydrobenzo[4,5]imidazo[1,2-a][1,3,5]triazine scaffold: synthesis and pharmacological effects 186
An irreversible ligand of the 18 kDa Translocator Protein induces rapidly ΔΨm collapse and activates apoptosis in human glioblastoma multiforme cells. 186
Discovery of the First-in-Class Dual TSPO/Carbonic Anhydrase Modulators with Promising Neurotrophic Activity 185
Modulation of A2B adenosine receptor by 1-benzyl-3-ketoindole derivatives 184
Targeting the 18-kDa translocator protein: Recent perspectives for neuroprotection 183
Modulation of A2B Adenosine Receptor by 1-Benzyl-3-ketoindole Derivatives 180
4-Substituted Benzenesulfonamides Incorporating Bi/Tricyclic Moieties Act as Potent and Isoform-Selective Carbonic Anhydrase II/IX Inhibitors 178
De novo neurosteroidogenesis in human microglia: Involvement of the 18 kda translocator protein 176
Long lasting MDM2/Translocator protein modulator: a new strategy for irreversible apoptosis of human glioblastoma cells 175
Carbonic anhydrase activation profile of indole-based derivatives 175
Iminothioethers as a novel class of H2S-donor: gasotransmitter release and vascular effects 171
Allosteric modulation of A2B adenosine receptors potentiate the effects of orthosteric receptor agonists to promote mesenchymal stem cell differentiation to osteoblasts. 168
Exploiting the 4-Phenylquinazoline Scaffold for the Development of High Affinity Fluorescent Probes for the Translocator Protein (TSPO) 168
Unbinding of Translocator Protein 18 kDa (TSPO) Ligands: From in Vitro Residence Time to in Vivo Efficacy via in Silico Simulations 165
Target-Based Anticancer Indole Derivatives for the Development of Anti-Glioblastoma Agents 162
Studies on enantioselectivity of chiral 4-acetylamino-6-alkyloxy-2-alkylthiopyrimidines acting as antagonists of the human A3 adenosine receptor 162
Refinement of the translocator protein pharmacophore/receptor model via structure-activity relationships of novel N,N-dialkylindolylglyoxylamides 159
2-(phenylsulphonamido)-pyrazole derivatives as carbonic anhydrase inhibitors 159
Allosteric Modulators of Adenosine Receptors 157
Targeting the Translocator Protein (18 kDa) in Cardiac Diseases: State of the Art and Future Opportunities 155
Indol-3-ylglyoxylamide as Privileged Scaffold in Medicinal Chemistry 155
Lead Optimization of 2-Phenylindolylglyoxylyldipeptide Murine Double Minute (MDM)2/Translocator Protein (TSPO) Dual Inhibitors for the Treatment of Gliomas 154
Tetrahydroquinazole-based secondary sulphonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IV, and IX, and computational studies 154
Structure-Activity Relationship Refinement and Further Assessment of 4-Phenylquinazoline-2-carboxamide Translocator Protein Ligands as Antiproliferative Agents in Human Glioblastoma Tumors. 151
Allosterism vs. Orthosterism: Recent Findings and Future Perspectives on A2B AR Physio-Pathological Implications 151
Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of noncamptothecin Topoisomerase I (top1) inhibitors 150
Interaction of the irreversible ligand IRDE-MPIGA with TSPO (18 KDa): new insight on TSPO role in tumor cells. 148
Multiple Topoisomerase I (TopoI), Topoisomerase II (TopoII) and Tyrosyl-DNA Phosphodiesterase (TDP) inhibitors in the development of anticancer drugs 148
Design and synthesis of novel indolylglyoxylamide derivatives as molecular probes for 18 KDa translocator protein (TSPO) 146
3-Aryl-1,2,4-triazino-4,3-abenzimidazol-4(10H)-one: a novel template for the design of highly selective A2B adenosine receptor antagonists 145
Diruthenium(ii,iii) paddlewheel complexes: effects of bridging and axial ligands on anticancer properties 143
Refinement of the Mitochondrial Translocator Protein Pharmacophore/Receptor Model via Structure-activity Relationships of Novel N,N-Dialkylindolylglyoxylamides 141
Anti-Proliferative Properties of the Novel Hybrid Drug Met-ITC, Composed of the Native Drug Metformin with the Addition of an Isothiocyanate H2S Donor Moiety, in Different Cancer Cell Lines 141
Dual Targeting Topoisomerase/G-Quadruplex Agents in Cancer Therapy-An Overview 140
Oxaliplatin(IV) Prodrugs Functionalized with Gemcitabine and Capecitabine Induce Blockage of Colorectal Cancer Cell Growth - An Investigation of the Activation Mechanism and Their Nanoformulation 138
From conventional therapy to novel nano-based approaches. A focus on prostate cancer 138
Cancer Immunotherapy: An Overview on Small Molecules as Inhibitors of the Immune Checkpoint PD-1/PD-L1 (2015-2021) 138
Pursuing Polypharmacology: Benzothiopyranoindoles as G-Quadruplex Stabilizers and Topoisomerase I Inhibitors for Effective Anticancer Strategies 137
Benzoxadiazole Derivatives: Atypical Inhibitors of Aldose Reductase 136
Glioblastoma multiforme: induction of mitochondria-mediated apoptotic pathway by simultaneous pharmacological activation of TSPO (18KDa) and p53. 136
N,N-dialkyl-5-isothiocyanato-2-phenylindol-3-ylglyoxylamide: an irreversible ligand to study the translocator protein 135
Development of a New A2B Adenosine Receptors PET ligand: 3- Phenyl-1-[11C]methyl-3- aryl[1,2,4]triazino[4,3 -a]benzimidazol-4(10H)-one 132
Development of novel indole-based tdp1 inhibitors for anticancer therapy 130
New suitable scaffolds for the development of non camptothecin topoisomerase I (Top1) inhibitors 127
Enhancing the Anticancer Activity of Attenuated Listeria monocytogenes by Cell Wall Functionalization with “Clickable” Doxorubicin 126
Refinement of the Mitochondrial Translocator Protein Pharmacophore/Receptor Model via Structure-activity Relationships of Novel N,N-Dialkylindolylglyoxylamides 126
Iminothioethers As A Novel Class Of H2s-Donor: Gasotransmitter Release And Vascular Effects 124
Essential Principles and Recent Progress in the Development of TSPO PET Ligands for Neuroinflammation Imaging 124
Discovery of N-substituted-2-oxoindolin benzoylhydrazines as c-MET/SMO modulators in EGFRi-resistant non-small cell lung cancer 123
Indole-based modulators of p53/MDM2 interaction as antitumoral agents 121
Indole-Based Compounds in the Development of Anti-Neurodegenerative Agents 119
2-(Phenylamino)-7,8-dihydroquinazolin-5(6H)-one, a promising scaffold for MAO-B inhibitors with potential GSK3β targeting 118
H2S-releasing properties of new thioamide derivatives 115
Strategies for the improvement of metal-based chemotherapeutic treatments 115
Novel 2-substituted-benzimidazole-6-sulfonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IX and XII and molecular docking studies 111
Drug repurposing meets DNA independent pathways: targeting alternative substrates for anticancer therapy 105
Carbonic Anhydrase Activators for Neurodegeneration: An Overview 102
Lead optimization of a novel molecular scaffold in search for novel MMP-13 inhibitors 98
Enriching the arsenal of pharmacological tools against mical2 98
Radiosynthesis of the TSPO 18 kDa PET Radiotracer [18F](R)-PK14105 97
Tyrosine kinase inhibitors (TKIs) for ovarian cancer treatment: from organic to inorganic chemotherapeutics towards selectivity-a perspective overview 95
Modulation of PAR1 signaling by benzimidazole compounds 93
Indole-based modulators of p53/MDM2 interaction as antitumoral agents 93
Refinement of the Mitochondrial Translocator Protein Pharmacophore/Receptor Model via Structure-activity Relationships of Novel N,N-Dialkylindolylglyoxylamides. 92
Labeling of TSPO PET radioligands by [18F]fluorination of diarylsulfoxide precursors 84
N,N-dialkyl-5-isothiocyanato-2-phenylindol-3-ylglyoxylamide: an irreversible ligand to study the translocator protein 83
Totale 17.175
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.595
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.595
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022996 0 91 53 39 137 166 55 46 34 34 45 296
2022/20231.532 162 207 127 146 151 190 14 97 324 13 71 30
2023/20241.123 59 72 104 40 119 249 129 44 11 30 131 135
2024/20253.916 31 111 56 203 347 414 268 136 361 449 439 1.101
2025/20265.694 254 582 560 463 539 377 1.396 245 370 492 215 201
2026/2027618 147 471 0 0 0 0 0 0 0 0 0 0
Totale 17.604